logo logo
Search: Organ site Search: Tumor / Syndrome
WHO Classification of Tumours
Somatostatinoma, malignant
Small intestine


A somatostatinoma is a functionally active and usually malignant endocrine tumour with evidence of D-cell differentiation and clinical symptoms reflecting the diverse pathophysiologic effects of chronic inappropriate secretion of somatostatin (hypersomatostatinemia; somatostatinoma syndrome)
Click for details
Ronald A. DeLellis, Ricardo V. Lloyd, Philipp U. Heitz, Charis Eng
World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Endocrine Organs
IARC Press: Lyon 2004

. Somatostatinomas account for between 1 to 2% of endocrine tumours of the gastroenteropancreaticohepatic (GEPH) axis and generally arise in adults. Some somatostatinomas are associated with NF1, MEN1 and Von Hippel-Lindau syndromes; the etiology of their sporadic counterparts is unclear. Because somatostatinomas are generally large by the time they are detected, nearly two-thirds have already metastasized to the regional lymph nodes or the liver
Click to access Pubmed
Axelrod L, Bush MA, Hirsch HJ, Loo SW (1981)
Malignant somatostatinoma: clinical features and metabolic studies.
J Clin Endocrinol Metab 52: 886-96

Click to access Pubmed
Shirouzu K, Miyamoto Y, Shiramizu T, Morimatsu M (1985)
Somatostatinoma of the pancreas.
Acta Pathol Jpn 35: 1285-92


Commentary: Neuroendocrine tumours of the digestive system